COVID-19重症患者营养治疗专家建议

2020-07-20 中华医学会肠外肠内营养学分会 中国科学: 生命科学, 2020, 50.

重症患者是治疗的重点, 其预后更差; 也是治疗的难点, 其消耗的人力物力财力更多.COVID-19是一个全新的挑战, 没有现成的循证医学依据可循. 为提高COVID-19重症患者的治疗效果, 借鉴既往

中文标题:

COVID-19重症患者营养治疗专家建议

发布日期:

2020-07-20

简要介绍:

重症患者是治疗的重点, 其预后更差; 也是治疗的难点, 其消耗的人力物力财力更多.COVID-19是一个全新的挑战, 没有现成的循证医学依据可循. 为提高COVID-19重症患者的治疗效果, 借鉴既往的流感、HIV、MERS及SARS治疗经验, 以及美国营养与膳食学会把营养治疗推荐为HIV感染患者常规治疗的做法, 中国营养保健食品协会、中华医学会肠外肠内营养学分会、中国抗癌协会学术部、中国抗癌协会肿瘤营养专业委员会组织专家制定了《COVID-19重症患者营养治疗专家建议》。

相关资料下载:
[AttachmentFileName(sort=1, fileName=COVID_19重症患者营养治疗专家建议_石汉平.pdf)] GetToolGuiderByIdResponse(projectId=1, id=1fdda1c0019a68d3, title=COVID-19重症患者营养治疗专家建议, enTitle=, guiderFrom=中国科学: 生命科学, 2020, 50., authorId=0, author=, summary=重症患者是治疗的重点, 其预后更差; 也是治疗的难点, 其消耗的人力物力财力更多.COVID-19是一个全新的挑战, 没有现成的循证医学依据可循. 为提高COVID-19重症患者的治疗效果, 借鉴既往, cover=https://img.medsci.cn/202087/1596809729339_2020535.jpg, journalId=0, articlesId=null, associationId=240, associationName=中华医学会肠外肠内营养学分会, associationIntro=中华医学会组织管理部于2004年12月2~4日在北京组织召开了中华医学会肠外肠内营养学分会成立大会,该分会的特点是涵盖多学科肠外肠内营养。年会每两年召开一次。, copyright=0, guiderPublishedTime=Mon Jul 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>重症患者是治疗的重点, 其预后更差; 也是治疗的难点, 其消耗的人力物力财力更多.COVID-19是一个全新的挑战, 没有现成的循证医学依据可循. 为提高COVID-19重症患者的治疗效果, 借鉴既往的流感、HIV、MERS及SARS治疗经验, 以及美国营养与膳食学会把营养治疗推荐为HIV感染患者常规治疗的做法, 中国营养保健食品协会、中华医学会肠外肠内营养学分会、中国抗癌协会学术部、中国抗癌协会肿瘤营养专业委员会组织专家制定了《COVID-19重症患者营养治疗专家建议》。</p> </div> </div> </div>, tagList=[TagDto(tagId=16972, tagName=营养治疗), TagDto(tagId=102190, tagName= COVID-19)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=66, categoryName=营养科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=102190, guiderKeyword= COVID-19, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3492, appHits=235, showAppHits=0, pcHits=534, showPcHits=3257, likes=4, shares=24, comments=8, approvalStatus=1, publishedTime=Sat Aug 08 00:19:42 CST 2020, publishedTimeString=2020-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Aug 07 22:15:38 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 00:59:01 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=COVID_19重症患者营养治疗专家建议_石汉平.pdf)])
COVID_19重症患者营养治疗专家建议_石汉平.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=966657, encodeId=549296665e56, content=营养对于重症患者来说是非常值得关注的 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a93086786, createdName=1178831132, createdTime=Tue May 18 21:08:51 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909499, encodeId=5c9890949969, content=很好的学习资料。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6035442147, createdName=ms4000001515814293, createdTime=Sun Dec 20 08:55:27 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909086, encodeId=5f6690908617, content=很好,最好用不到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdf52577508, createdName=12599227m90暂无昵称, createdTime=Fri Dec 18 11:40:10 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901596, encodeId=25d8901596a9, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e15437547, createdName=ms1000001975947593, createdTime=Mon Nov 23 22:50:27 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896445, encodeId=2f6c89644541, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201011/e2ca7470d15a48b79e36ebda1367fcea/d3c4334ad5fb4f3b9d61cc60c5bbe540.jpg, createdBy=61ff3043223, createdName=398130289, createdTime=Tue Nov 03 00:14:00 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2021-05-18 1178831132

    营养对于重症患者来说是非常值得关注的

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=966657, encodeId=549296665e56, content=营养对于重症患者来说是非常值得关注的 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a93086786, createdName=1178831132, createdTime=Tue May 18 21:08:51 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909499, encodeId=5c9890949969, content=很好的学习资料。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6035442147, createdName=ms4000001515814293, createdTime=Sun Dec 20 08:55:27 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909086, encodeId=5f6690908617, content=很好,最好用不到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdf52577508, createdName=12599227m90暂无昵称, createdTime=Fri Dec 18 11:40:10 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901596, encodeId=25d8901596a9, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e15437547, createdName=ms1000001975947593, createdTime=Mon Nov 23 22:50:27 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896445, encodeId=2f6c89644541, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201011/e2ca7470d15a48b79e36ebda1367fcea/d3c4334ad5fb4f3b9d61cc60c5bbe540.jpg, createdBy=61ff3043223, createdName=398130289, createdTime=Tue Nov 03 00:14:00 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2020-12-20 ms4000001515814293

    很好的学习资料。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=966657, encodeId=549296665e56, content=营养对于重症患者来说是非常值得关注的 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a93086786, createdName=1178831132, createdTime=Tue May 18 21:08:51 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909499, encodeId=5c9890949969, content=很好的学习资料。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6035442147, createdName=ms4000001515814293, createdTime=Sun Dec 20 08:55:27 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909086, encodeId=5f6690908617, content=很好,最好用不到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdf52577508, createdName=12599227m90暂无昵称, createdTime=Fri Dec 18 11:40:10 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901596, encodeId=25d8901596a9, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e15437547, createdName=ms1000001975947593, createdTime=Mon Nov 23 22:50:27 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896445, encodeId=2f6c89644541, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201011/e2ca7470d15a48b79e36ebda1367fcea/d3c4334ad5fb4f3b9d61cc60c5bbe540.jpg, createdBy=61ff3043223, createdName=398130289, createdTime=Tue Nov 03 00:14:00 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2020-12-18 12599227m90暂无昵称

    很好,最好用不到

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=966657, encodeId=549296665e56, content=营养对于重症患者来说是非常值得关注的 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a93086786, createdName=1178831132, createdTime=Tue May 18 21:08:51 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909499, encodeId=5c9890949969, content=很好的学习资料。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6035442147, createdName=ms4000001515814293, createdTime=Sun Dec 20 08:55:27 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909086, encodeId=5f6690908617, content=很好,最好用不到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdf52577508, createdName=12599227m90暂无昵称, createdTime=Fri Dec 18 11:40:10 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901596, encodeId=25d8901596a9, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e15437547, createdName=ms1000001975947593, createdTime=Mon Nov 23 22:50:27 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896445, encodeId=2f6c89644541, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201011/e2ca7470d15a48b79e36ebda1367fcea/d3c4334ad5fb4f3b9d61cc60c5bbe540.jpg, createdBy=61ff3043223, createdName=398130289, createdTime=Tue Nov 03 00:14:00 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2020-11-23 ms1000001975947593

    学习好资料

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=966657, encodeId=549296665e56, content=营养对于重症患者来说是非常值得关注的 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2a93086786, createdName=1178831132, createdTime=Tue May 18 21:08:51 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909499, encodeId=5c9890949969, content=很好的学习资料。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b6035442147, createdName=ms4000001515814293, createdTime=Sun Dec 20 08:55:27 CST 2020, time=2020-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909086, encodeId=5f6690908617, content=很好,最好用不到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fdf52577508, createdName=12599227m90暂无昵称, createdTime=Fri Dec 18 11:40:10 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901596, encodeId=25d8901596a9, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34e15437547, createdName=ms1000001975947593, createdTime=Mon Nov 23 22:50:27 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896445, encodeId=2f6c89644541, content=这个好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201011/e2ca7470d15a48b79e36ebda1367fcea/d3c4334ad5fb4f3b9d61cc60c5bbe540.jpg, createdBy=61ff3043223, createdName=398130289, createdTime=Tue Nov 03 00:14:00 CST 2020, time=2020-11-03, status=1, ipAttribution=)]
    2020-11-03 398130289

    这个好

    0

拓展阅读

2020 ESE声明:COVID-19和内分泌疾病

欧洲内分泌学会(ESE,European Society of Endocrinology) · 2020-04-11

2020 韩国COVID-19实验室诊断指南

韩国检验医学学会(KSLM,Korean Society for Laboratory Medicine) · 2020-04-20

2020 ESGE/ESGENA立场声明:胃肠内镜检查和COVID-19流行

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2020-04-17

2020 IDSA指南:COVID-19患者的治疗和管理

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2020-04-27

2020 国际专家小组实践声明:COVID-19流行期间支气管镜检查

国外呼吸科专家组(统称) · 2020-04-28

2020 ESTRO/ASTRO共识声明:COVID-19流行期间肺癌的放疗建议

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2020-04-06